Albuterol Sulfate Inhalation Solution
Product Images NDC 67296-1867

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Albuterol Sulfate Inhalation Solution (NDC 67296-1867). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

0.63 mg Brick Carton (0 63 mg Carton Brick)

0.63 mg Brick Carton (0 63 mg Carton Brick)
Packaging label for Albuterol Sulfate Inhalation Solution 0.63 mg/3 mL by RedPharm Drug. The label includes product name, strength, dosage form, NDC number, usage instructions, storage conditions, active ingredient, and barcode. The design features orange highlights and illustrations of the unit-dose vial.*
FDA Label Image

0.63 mg Cards Carton (0 63 mg Carton Cards)

0.63 mg Cards Carton (0 63 mg Carton Cards)
Packaging label for Albuterol Sulfate Inhalation Solution 0.63 mg/3 mL. The carton is marked for sterile unit-dose vials, containing 5 pouches of 5 x 3 mL vials each. The label shows the NDC 76204-010-55 and includes the brand name, strength, volume, manufacturer Ritedose Pharmaceutical, and an illustration of a unit-dose vial.*
FDA Label Image

0.63 mg Singles Carton (0 63 mg Carton Singles)

0.63 mg Singles Carton (0 63 mg Carton Singles)
Packaging label for Albuterol Sulfate Inhalation Solution, 0.63 mg per 3 mL unit-dose vials. Label states the medication is for inhalation only and supplied as sterile unit-dose vials. The carton contains 30 pouches of one 3 mL vial each. Labeler is RedPharm Drug. The label includes barcodes and an illustration of the unit-dose vial.*
FDA Label Image

1.25 mg Brick Carton (1 25 mg Carton Brick)

1.25 mg Brick Carton (1 25 mg Carton Brick)
Packaging label for Albuterol Sulfate Inhalation Solution 1.25 mg/3 mL by RedPharm Drug. The carton includes dosage information, barcode, NDC 76204-011-25, and illustrations of the single-dose vial. It specifies sterile unit-dose vials for inhalation use only, with storage and ingredient information.*
FDA Label Image

1.25 mg Cards Carton (1 25 mg Carton Cards)

1.25 mg Cards Carton (1 25 mg Carton Cards)
Packaging label for Albuterol Sulfate Inhalation Solution 1.25 mg per 3 mL by RedPharm Drug. The carton contains 5 pouches, each with 3 mL of sterile unit-dose vials. The label includes a barcode, usage information, and storage instructions, with a teal highlight around the dosage strength and a small vial illustration.*
FDA Label Image

1.25 mg Singles Carton (1 25 mg Carton Singles)

1.25 mg Singles Carton (1 25 mg Carton Singles)
Packaging label for Albuterol Sulfate Inhalation Solution 1.25 mg/3 mL. The label includes the product name, strength, and dosage form, with images of an inhalation solution vial. The label states it is for inhalation only and contains sterile unit-dose vials. The manufacturer is indicated as Ritedose Pharmaceuticals LLC. Barcodes and NDC codes (76204-011-01) appear on the label.*
FDA Label Image

Image-01 (Image 01)

Image-01 (Image 01)
Chemical structure of albuterol sulfate, showing two albuterol molecules with attached sulfate groups, as part of the Albuterol Sulfate Inhalation Solution by RedPharm Drug.*
FDA Label Image

Image-02 (Image 02)

Image-02 (Image 02)
A line graph displaying percent change over time in hours from pre-dose for treatments with Albuterol 1.25 mg, Albuterol 0.63 mg, and placebo. The x-axis represents hours from 0 to 6, and the y-axis shows percent change from 0 to 30%. The graph includes three lines comparing the effects of the two albuterol doses versus placebo over the 6-hour period.*
FDA Label Image

Image-03 (Image 03)

Image-03 (Image 03)
A line graph showing percent change over time (hours from pre-dose) for three treatments: albuterol 1.25 mg, albuterol 0.63 mg, and placebo. The graph illustrates the change in response from 0 to 6 hours post-dose for each treatment group, with values on the y-axis representing percent change and x-axis representing hours since pre-dose.*
FDA Label Image

Image-04 (Image 04)

Image-04 (Image 04)
An instructional illustration showing hands assembling a metered-dose inhaler by inserting a dose from an inhalation solution vial into the device. The image emphasizes the preparation steps for using the Albuterol Sulfate Inhalation Solution inhaler.*
FDA Label Image

Image-05 (Image 05)

Image-05 (Image 05)
An instructional illustration demonstrating the attachment of the mouthpiece to a medication inhaler device. The image shows a hand holding the inhaler while positioning the mouthpiece for connection.*
FDA Label Image

Image-06 (Image 06)

Image-06 (Image 06)
Instructional illustration showing two methods of using a nebulizer inhalation device. Figure 3 depicts a person inhaling through a mouthpiece held in their mouth. Figure 4 shows a person using a face mask attached to the nebulizer.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.